Search research articles
Contact Us
Filters
Showing results (281-290 of 464) with videos related to
Page
of 47
Sort By:
Journal of Crohn'S & Colitis
|
June 20, 2018
Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension
Walter Reinisch, Peter R Gibson, William J Sandborn, et al.
Gastroenterology
|
June 18, 2018
Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease
Paul Rutgeerts, Christopher Gasink, Daphne Chan, et al.
Digestive Diseases and Sciences
|
June 28, 2023
Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn's Disease: Systematic Review and Meta-Analysis
Sudheer Kumar Vuyyuru, Virginia Solitano, Malcolm Hogan, et al.
Gastroenterology
|
August 2, 2003
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial
William J Sandborn, Daniel H Present, Kim L Isaacs, et al.
Journal of Crohn'S & Colitis
|
May 22, 2019
Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Christopher Ma, Nicola R Panaccione, Tran M Nguyen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 28, 2017
Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set
Christopher Ma, Remo Panaccione, Richard N Fedorak, et al.
Journal of Crohn'S & Colitis
|
February 4, 2024
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis
Subrata Ghosh, Brian G Feagan, Elyssa Ott, et al.
Inflammatory Bowel Diseases
|
October 27, 2018
Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
Brian G Feagan, Stefan Schreiber, Douglas C Wolf, et al.
The American Journal of Gastroenterology
|
April 12, 2006
Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease
Gary R Lichtenstein, Allan Olson, Suzanne Travers, et al.
European Journal of Gastroenterology & Hepatology
|
February 7, 2025
Directionality of endoscopic and histologic healing in ulcerative colitis: a prospective pilot study
Jurij Hanžel, Gregor Novak, Vipul Jairath, et al.
Page
of 47
Search research articles
Search
Showing results (281-290 of 464) with videos related to
Sort By:
Page
of 47
Journal of Crohn'S & Colitis
|
June 20, 2018
Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension
Walter Reinisch, Peter R Gibson, William J Sandborn, et al.
Gastroenterology
|
June 18, 2018
Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease
Paul Rutgeerts, Christopher Gasink, Daphne Chan, et al.
Digestive Diseases and Sciences
|
June 28, 2023
Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn's Disease: Systematic Review and Meta-Analysis
Sudheer Kumar Vuyyuru, Virginia Solitano, Malcolm Hogan, et al.
Gastroenterology
|
August 2, 2003
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial
William J Sandborn, Daniel H Present, Kim L Isaacs, et al.
Journal of Crohn'S & Colitis
|
May 22, 2019
Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Christopher Ma, Nicola R Panaccione, Tran M Nguyen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 28, 2017
Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set
Christopher Ma, Remo Panaccione, Richard N Fedorak, et al.
Journal of Crohn'S & Colitis
|
February 4, 2024
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis
Subrata Ghosh, Brian G Feagan, Elyssa Ott, et al.
Inflammatory Bowel Diseases
|
October 27, 2018
Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
Brian G Feagan, Stefan Schreiber, Douglas C Wolf, et al.
The American Journal of Gastroenterology
|
April 12, 2006
Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease
Gary R Lichtenstein, Allan Olson, Suzanne Travers, et al.
European Journal of Gastroenterology & Hepatology
|
February 7, 2025
Directionality of endoscopic and histologic healing in ulcerative colitis: a prospective pilot study
Jurij Hanžel, Gregor Novak, Vipul Jairath, et al.
Page
of 47